Search Results - "Khokhar, A R"
-
1
Recruitment of trimeric proliferating cell nuclear antigen by G1-phase cyclin-dependent kinases following DNA damage with platinum-based antitumour agents
Published in British journal of cancer (29-10-2013)“…Background: In cycling tumour cells, the binary cyclin-dependent kinase Cdk4/cyclin D or Cdk2/cyclin E complex is inhibited by p21 following DNA damage to…”
Get full text
Journal Article -
2
Distinct Features of Vascular Diseases in COVID-19
Published in Journal of inflammation research (01-01-2023)“…The Coronavirus Disease 2019 (COVID-19) pandemic was declared in early 2020 after several unexplained pneumonia cases were first reported in Wuhan, China, and…”
Get full text
Journal Article -
3
Upregulation of p27 and its inhibition of CDK2 cyclin E activity following DNA damage by a novel platinum agent are dependent on the expression of p21
Published in British journal of cancer (04-12-2006)“…The cisplatin analogue 1R,2R-diaminocyclohexane(trans-diacetato)(dichloro)platinum(IV) (DAP) is a DNA-damaging agent that will be entering clinical trials for…”
Get full text
Journal Article -
4
Are Medical Students from Across the World Aware of Cervical Cancer, HPV Infection and Vaccination? A Cross-Sectional Comparative Study
Published in Journal of cancer education (01-08-2021)“…This study aims to understand and compare the level of knowledge, the attitude and the awareness of cervical cancer, HPV infection and vaccination among…”
Get full text
Journal Article -
5
Phase I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato(trans-R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar liposome vesicles
Published in Journal of cancer research and clinical oncology (01-10-2003)“…To perform a phase I study of intraperitoneal cis-bis-neodecanoato ( trans- R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar vesicles…”
Get full text
Journal Article -
6
Expression of p53 in Cisplatin-resistant Ovarian Cancer Cell Lines: Modulation with the Novel Platinum Analogue (1R, 2R-Diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV)
Published in Clinical cancer research (01-03-1999)“…The compound ( 1R , 2R -diaminocyclohexane)( trans -diacetato)(dichloro)platinum(IV) (DACH-acetato-Pt) is a novel platinum-based antitumor agent with clinical…”
Get full text
Journal Article -
7
Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions
Published in Clinical cancer research (01-03-1997)“…cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) (NDDP) is a lipophilic non-cross-resistant platinum compound formulated in large…”
Get full text
Journal Article -
8
Intraliposomal chemical activation patterns of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II) (L-NDDP)-a potential antitumour agent
Published in Journal of microencapsulation (01-05-2000)“…L-NDDP is a liposome-entrapped platinum compound currently in phase 2 clinical trials that has been shown to undergo intraliposomal activation. The…”
Get full text
Journal Article -
9
Synthesis, characterization and cytotoxicity of new Platinum(IV) axial carboxylate complexes : Crystal structure of potential antitumor agent [PtIV(trans-1R, 2R-Diaminocyclohexane)trans(acetate)2Cl2]
Published in Bioorganic & medicinal chemistry (01-03-2000)“…A series of new platinum(IV) complexes of the type [PtIV(DACH)trans(L)2Cl2] (where DACH = trans-1R,2R-diaminocyclohexane, and L = acetate, propionate,…”
Get full text
Journal Article -
10
Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities
Published in Oncogene (21-04-2005)“…DNA damage often activates the p53-p21 pathway and causes G(1)-phase arrest in mammalian cells. Although there is ample evidence that p21 induction by p53…”
Get full text
Journal Article -
11
Chemical and Biological Studies on a Series of Novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-Diaminocyclohexane)platinum(IV) Carboxylate Complexes
Published in Journal of medicinal chemistry (03-01-1997)“…A series of novel platinum(IV) complexes of the type DACH-PtIV-trans-(Y)2-cis-X (where DACH = trans-(1R,2R)-, trans-(1S,2S)-, or cis-1,2-diaminocyclohexane; X…”
Get full text
Journal Article -
12
Bimodal Effects of 1R,2R-Diaminocyclohexane(trans-diacetato)(dichloro)platinum(IV) on Cell Cycle Checkpoints
Published in Clinical cancer research (01-11-2001)“…1R , 2R -Diaminocyclohexane( trans -diacetato)(dichloro)- platinum(IV) (DACH-acetato-Pt) is a novel platinum-based agent that is highly effective against…”
Get full text
Journal Article -
13
Role of p53 in the ability of 1,2-diaminocyclohexane-diacetato-dichloro-Pt(IV) to circumvent cisplatin resistance
Published in Journal of inorganic biochemistry (01-10-1999)“…Several reports indicate that the mechanism of resistance to cisplatin is multifactorial. However, DNA damage tolerance appears to be the more significant…”
Get full text
Journal Article -
14
Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV)
Published in Cancer research (Chicago, Ill.) (01-09-1994)“…A platinum(II) and 3 platinum(IV) ammine/cycloalkylamine homologous series were evaluated for cytotoxicity and biochemical pharmacology in murine leukemia…”
Get full text
Journal Article -
15
Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II)
Published in Cancer research (Chicago, Ill.) (15-07-1990)“…cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum++ +(II) (NDDP) is a liposome dependent cisplatin analogue since the liposome carrier is required…”
Get full text
Journal Article -
16
Preparation, characterization, and antitumor activity of new ethylenediamine platinum(IV) complexes containing mixed carboxylate ligands
Published in Journal of inorganic biochemistry (01-05-1993)“…A series of ethylenediamine platinum(IV) complexes of the type PtIV(en)XA2 and PtIV(en)X'2A2, where X = 1,1-cyclobutanedicarboxylato or malonato, X' = chloro,…”
Get more information
Journal Article -
17
Pharmacokinetics of intravenously injected [3H]tetrachloro(D,L-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin) in mice
Published in Drug metabolism and disposition (01-09-1992)“…Platinum (Pt) complexes with diaminocyclohexane (DACH) carrier ligand are of interest because of their effectiveness against tumor cells resistant to…”
Get more information
Journal Article -
18
Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats
Published in British journal of cancer (01-09-1993)“…Acute haematological toxicity induced by cis-diammine-1,1-cyclobutane dicarboxylate platinum (II) (carboplatin) and cis-diamminedichloroplatinum (II)…”
Get full text
Journal Article -
19
Pharmacokinetics of tetraplatin administered intraperitoneally with reduced glutathione in mice
Published in Drug metabolism and disposition (01-03-1994)“…Tetraplatin (Ormaplatin) has been developed as a second generation platinum complex because of its good antitumor activity against some cisplatin-resistant…”
Get more information
Journal Article -
20
Lipophilic cisplatin analogues entrapped in liposomes : role to intraliposomal drug activation in biological activity
Published in Cancer research (Chicago, Ill.) (15-11-1992)“…cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II) (NDDP), a lipophilic cisplatin analogue containing two branched leaving groups of 10 carbon…”
Get full text
Journal Article